Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease. [electronic resource]
Producer: 20170818Description: 1641-1649.e6 p. digitalISSN:- 1097-6825
- Adolescent
- Adult
- CD4-Positive T-Lymphocytes -- drug effects
- Child
- Child, Preschool
- Cytokines -- immunology
- Female
- Granulomatous Disease, Chronic -- immunology
- Humans
- Immunosuppressive Agents -- pharmacology
- Infant
- Inflammation -- immunology
- Interleukin 1 Receptor Antagonist Protein -- pharmacology
- Male
- Middle Aged
- Monocytes -- drug effects
- Phagocytes -- drug effects
- Sirolimus -- pharmacology
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.